.:. Consulter > Par domaine > Pharmacologie .:.

14 documents classés par :  date titre 1er auteur Type de documents Date de dépôt

1 - 2

Ingredients Tracking of Cosmetic Formulations in the Skin: A Confocal Raman Microscopy Investigation Foerster M., Bolzinger M.-A., Ach D., Montagnac G., Briançon S. Pharmaceutical Research 28, 4 (2011) 858-872 [insu-00683915 - version 1]

2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group. Farge D., Bosquet L., Kassab-Chahmi D., Mismetti P., Elalamy I., Meyer G., Cajfinger F., Desmurs-Clavel H., Elias A., Grange C. et al Critical Reviews in Oncology/Hematology (2009) epub ahead of print [ujm-00439710 - version 1]

The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples. Cochery-Nouvellon E., Chauleur C., Demattei C., Mercier E., Fabbro-Peray P., Marès P., Mismetti P., Lissalde-Lavigne G., Gris J.-C. Thrombosis and Haemostasis 102, 4 (2009) 656-67 [ujm-00439708 - version 1]

(Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients) Elias A., Debourdeau P., Renaudin J. M., Desmurs-Clavel H., Mahé I., Elalamy I., Pavic M., Kassab-Chahmi D., Bosquet L., Cajfinger F. et al Presse Médicale (Paris, France : 1983) 38, 2 (2009) 220-30 [ujm-00439726 - version 1]

Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. Chauleur C., Cochery-Nouvellon E., Mercier E., Aya G., Fabbro-Peray P., Mismetti P., Lissade-Lavigne G., Gris J.-C. Journal of Thrombosis and Haemostasis 6, 12 (2008) 2067-74 [ujm-00439739 - version 1]

Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort. Chauleur C., Cochery-Nouvellon E., Mercier E., Aya G., Marès P., Mismetti P., Lissalde-Lavigne G., Gris J.-C. Thrombosis and Haemostasis 100, 5 (2008) 773-9 [ujm-00439736 - version 1]

(2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients) , Mahé I., Elalamy I., Farge-Bancel D., Mismetti P., Scrobohaci M.-L., Hocini H., Meyer G., Kassab-Chahmi D., Bosquet L. et al Journal des Maladies Vasculaires 33, 3 (2008) 140-54 [ujm-00439730 - version 1]

(2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients) Debourdeau P., Farge-Bancel D., Bosquet L., Kassab-Chahmi D., Cajfinger F., Desmurs-Clavel H., Desruennes E., Douard M.-C., Elias A., Elalamy I. et al Bulletin du Cancer 95, 7 (2008) 750-61 [ujm-00439743 - version 1]

(Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer) Kriegel I., Desruennes E., Douard M.-C., Grange C., Renaudin J. M., Meyer G., Scrobohaci M.-L., Kassab-Chahmi D., Bosquet L., Cajfinger F. et al Ann Fr Anesth Reanim 27, 6 (2008) 521-33 [ujm-00439745 - version 1]

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. Mas J.-L., Chatellier G., Beyssen B., Branchereau A., Moulin T., Becquemin J.-P., Larrue V., Lièvre M., Leys D., Bonneville J.-F. et al The New England Journal of Medicine 355, 16 (2006) 1660-71 [ujm-00440338 - version 1]